Larvol Delta - Equillium-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Corporate-and-Clinical-Highlights

Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma

https://www.businesswire.com/news/home/20250327561276/en/Equillium-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Corporate-and-Clinical-Highlights

Mar 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next